Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Sesen Bio, Inc. | d854880dex312.htm |
| EX-23.1 - EXHIBIT 23.1 - Sesen Bio, Inc. | d854880dex231.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Sesen Bio, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Sesen Bio, Inc. | d854880d10k.htm |
| EX-31.1 - EXHIBIT 31.1 - Sesen Bio, Inc. | d854880dex311.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. §1350
In connection with the Annual Report on Form 10-K of Eleven Biotherapeutics, Inc. (the “Company”) for the fiscal year ended December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, that, to the best of their knowledge:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Abbie C. Celniker |
| Abbie C. Celniker |
| President and Chief Executive Officer |
| (Principal Executive Officer) |
Dated: March 6, 2015
| /s/ Gregory D. Perry |
| Gregory D. Perry |
| Chief Financial and Business Officer |
| (Principal Financial Officer) |
Dated: March 6, 2015